Using the entire CLEO-c c ð3770Þ ! D " D event sample, corresponding to an integrated luminosity of 818 pb À1 and approximately 5:4 Â 10 6 D " D events, we present a study of the decays D 0 ! À e þ e , D 0 ! K À e þ e , D þ ! 0 e þ e , and D þ ! " K 0 e þ e . Via a tagged analysis technique, in which one D is fully reconstructed in a hadronic mode, partial rates for semileptonic decays by the other D are measured in several q 2 bins. We fit these rates using several form factor parametrizations and report the results, including form factor shape parameters and the branching fractions BðD 0 ! À e þ e Þ ¼ ð0:288 AE 0:008 AE 0:003Þ%, BðD 0 ! K À e þ e Þ ¼ ð3:50 AE 0:03 AE 0:04Þ%, BðD þ ! 0 e þ e Þ ¼ ð0:405 AE 0:016 AE 0:009Þ%, and BðD þ ! "K 0 e þ e Þ ¼ ð8:83 AE 0:10 AE 0:20Þ%, where the first uncertainties are statistical and the second are systematic. Taking input from lattice quantum chromodynamics, we also find jV cd j ¼ 0:234 AE 0:007 AE 0:002 AE 0:025 and jV cs j ¼ 0:985 AE 0:009 AE 0:006 AE 0:103, where the third uncertainties are from lattice quantum chromodynamics.
We have observed bottom-charm mesons via the decay mode B-c(+/-) --> J/psi l(+/-)v in 1.8 TeV p (p) over bar collisions using the CDF detector at the Fermilab Tevatron. A fit of background and signal contributions to the J/psi l mass distribution yielded 20.4(-5.5)(+6.2) events from B-c mesons. A fit to the same distribution with background alone was rejected at the level of 4.8 standard deviations. We measured the B-c(+) mass to be 6.40 +/- 0.39(stat) +/- 0.13(syst) GeV/c(2) and the B-c(+) lifetime to be 0.46(-0.16)(+0.18)(stat) +/- 0.03(syst) ps. Our measured yield (production cross section times branching ratio) for B-c(+) --> J/psi l(+)v relative to that for B+ --> J/psi K+ is 0.132(-0.037)(+0.041)(stat) +/- 0.031 (syst)(-0.020)(+0.032)(lifetime)
Using 20.7 pb −1 of e + e − annihilation data taken at √ s = 3.671 GeV with the CLEO-c detector, precision measurements of the electromagnetic form factors of the charged pion, charged kaon, and proton have been made for timelike momentum transfer of |Q 2 | = 13.48 GeV 2 by the reaction e + e − → h + h − . The measurements are the first ever with identified pions and kaons of |Q 2 | > 4 GeV 2 , with the results F π (13.48 GeV 2 ) = 0.075 ± 0.008(stat) ± 0.005(syst) and F K (13.48 GeV 2 ) = 0.063±0.004(stat)±0.001(syst). The result for the proton, assumingGeV 2 ) = 0.014 ± 0.002(stat) ± 0.001(syst), which is in agreement with earlier results.
have interest in AuraSense Therapeutics, which develops SNAbased technologies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the sponsors or government, and no official endorsement should be inferred. Data and materials availability: SNA conjugates and Bcl2L12-related biologicals are available upon request from C.A.M. and A.H.S. with an executed materials transfer agreement.
Using data collected with the CLEO detector operating at the CESR e+e- collider at sqrt[s]=3.97-4.26 GeV, we investigate 15 charmonium decay modes of the psi(4040), psi(4160), and Y(4260) resonances. We confirm, at 11 sigma significance, the BABAR Y(4260)-->pi+pi- J/psi discovery, make the first observation of Y(4260)--> pi(0)pi(0) J/psi (5.1 sigma), and find the first evidence for Y(4260)-->K+K- J/psi(3.7 sigma). We measure e+e- cross sections at sqrt[s]=4.26 GeV as sigma(pi+pi- J/psi)=58(+12)(-10)+/-4 pb, sigma(pi(0)pi(0) J/psi)=23(+12)(-8)+/-1 pb, and sigma(K+K- J/psi)=9(+9)(-5)+/-1 pb, in which the uncertainties are statistical and systematic, respectively. Upper limits are placed on other decay rates from all three resonances.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.